539428 — Tejnaksh Healthcare Income Statement
0.000.00%
Last trade - 00:00
- IN₹506.42m
- IN₹510.43m
- IN₹121.75m
- 97
- 38
- 35
- 61
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 168 | 120 | 127 | 117 | 122 |
Cost of Revenue | |||||
Gross Profit | 155 | 111 | 113 | 103 | 109 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 137 | 89.3 | 85.4 | 87.7 | 93.8 |
Operating Profit | 30.3 | 30.3 | 41.3 | 29.6 | 27.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 29.7 | 26.7 | 37.6 | 25.1 | 23.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 21.5 | 20.7 | 28.1 | 17.9 | 17.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 20.9 | 20.5 | 27.2 | 16.8 | 17.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 20.9 | 20.5 | 27.2 | 16.8 | 17.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.03 | 1.01 | 1.36 | 0.828 | 0.87 |